Literature DB >> 19504504

Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.

A Tabor1, C H F Vestergaard, Ø Lidegaard.   

Abstract

OBJECTIVE: To assess the fetal loss rate following amniocentesis and chorionic villus sampling (CVS).
METHODS: This was a national registry-based cohort study, including all singleton pregnant women who had an amniocentesis (n = 32 852) or CVS (n = 31 355) in Denmark between 1996 and 2006. Personal registration numbers of women having had an amniocentesis or a CVS were retrieved from the Danish Central Cytogenetic Registry, and cross-linked with the National Registry of Patients to determine the outcome of each pregnancy. Postprocedural fetal loss rate was defined as miscarriage or intrauterine demise before 24 weeks of gestation.
RESULTS: The miscarriage rates were 1.4% (95% CI, 1.3-1.5) after amniocentesis and 1.9% (95% CI, 1.7-2.0) after CVS. The postprocedural loss rate for both procedures did not change during the 11-year study period, and was not correlated with maternal age. The number of procedures a department performed had a significant effect on the risk of miscarriage. In departments performing fewer than 500 amniocenteses, the odds ratio for fetal loss was 2.2 (95% CI, 1.6-3.1) when compared to departments performing more than 1500 procedures during the 11-year period. For CVS the risk of miscarriage was 40% greater in departments performing 500-1000 and 1001-1500 as compared to those performing more than 1500 procedures.
CONCLUSIONS: The miscarriage rates (i.e. spontaneous loss and procedure-related loss) after amniocentesis and CVS were 1.4% and 1.9%, respectively. This difference may be explained by the difference in gestational age at the time of the procedures. The miscarriage rate was inversely correlated with the number of procedures performed in a department. (c) 2009 ISUOG.

Entities:  

Mesh:

Year:  2009        PMID: 19504504     DOI: 10.1002/uog.6377

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  24 in total

1.  Genetics and bioethics: how our thinking has changed since 1969.

Authors:  LeRoy Walters
Journal:  Theor Med Bioeth       Date:  2012-02

Review 2.  Disorders of sex development: effect of molecular diagnostics.

Authors:  John C Achermann; Sorahia Domenice; Tania A S S Bachega; Mirian Y Nishi; Berenice B Mendonca
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

3.  The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.

Authors:  Sarah Weiling Li; Angela Natalie Barrett; Leena Gole; Wei Ching Tan; Arijit Biswas; Hak Koon Tan; Mahesh Choolani
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

4.  Two families with sibling recurrence of the 17q21.31 microdeletion syndrome due to low-grade mosaicism.

Authors:  David A Koolen; Juliette Dupont; Nicole de Leeuw; Lisenka E L M Vissers; Simone P A van den Heuvel; Alyson Bradbury; James Steer; Arjan P M de Brouwer; Leo P Ten Kate; Willy M Nillesen; Bert B A de Vries; Michael J Parker
Journal:  Eur J Hum Genet       Date:  2012-02-01       Impact factor: 4.246

Review 5.  Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis.

Authors:  Stephanie A Devaney; Glenn E Palomaki; Joan A Scott; Diana W Bianchi
Journal:  JAMA       Date:  2011-08-10       Impact factor: 56.272

6.  The performance of MALBAC and MDA methods in the identification of concurrent mutations and aneuploidy screening to diagnose beta-thalassaemia disorders at the single- and multiple-cell levels.

Authors:  WeiQiang Liu; HuiMin Zhang; Dan Hu; SiJia Lu; XiaoFang Sun
Journal:  J Clin Lab Anal       Date:  2017-05-26       Impact factor: 2.352

7.  [Whole-transcriptome sequencing analysis of placental differential miRNA expression profile in Down syndrome].

Authors:  J He; J Tang; H Su; C Shen; S Luo; H Wang; Y Qian; M Lü
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-03-20

8.  Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities.

Authors:  Jean Gekas; David-Gradus van den Berg; Audrey Durand; Maud Vallée; Hajo Izaäk Johannes Wildschut; Emmanuel Bujold; Jean-Claude Forest; François Rousseau; Daniel Reinharz
Journal:  Eur J Hum Genet       Date:  2010-09-15       Impact factor: 4.246

Review 9.  Non-invasive prenatal testing: a review of international implementation and challenges.

Authors:  Megan Allyse; Mollie A Minear; Elisa Berson; Shilpa Sridhar; Margaret Rote; Anthony Hung; Subhashini Chandrasekharan
Journal:  Int J Womens Health       Date:  2015-01-16

Review 10.  Exome Sequencing in Fetuses with Structural Malformations.

Authors:  Fiona L Mackie; Keren J Carss; Sarah C Hillman; Matthew E Hurles; Mark D Kilby
Journal:  J Clin Med       Date:  2014-07-08       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.